Search results

Selected filters:

Litigation

Article type

Topic

Sector

Regions

3,243 results found for your search

Sort options
19 February 2019

With Oppo deal, Ericsson gets crucial SEP validation in China

Securing a FRAND licence with the world’s fifth largest handset maker could be a shot in the arm for the Swedish company, which has struggled to get royalties out of Chinese firms like Xiaomi and TCL

19 February 2019

New Acacia chief IP officer charts a different course for the once mighty NPE

Supported by a healthy balance sheet, Marc Booth says the firm plans on a higher volume of smaller deals with three new areas identified for future growth

18 February 2019

Rolling the dice on eligibility

Congressional action is the only way to solve the uncertainty on section 101 of the US patent statute, argues Aaric Eisenstein of Personalised Media Communications

15 February 2019

AbbVie’s Humira strategy to be scrutinised in first evergreening unclean hands challenge

In a Delaware case Boehringer Ingelheim accuses the Illinois company of improper conduct in deliberately constructing a patent thicket to protect against generic versions of its blockbuster drug.

14 February 2019

As 101 debate continues, Iancu offers clear message to Federal Circuit

With new guidelines set to reshape patent examination, the USPTO head makes the case for revisiting subject matter precedent

14 February 2019

World’s most valuable startup buys patents again

The company behind Tik Tok bought out much of a struggling smartphone maker’s patent portfolio in January. USPTO assignments from last week show what assets Beijing-based ByteDance came away with

13 February 2019

IPBC Global 2019 is shaping up to be the biggest and best of the series so far

Senior decision makers from a wide range of companies are already confirmed to attend as demand for tickets exceeds the rate for last year's sell-out event in San Francisco 

11 February 2019

RPX strikes deal to acquire remaining patent portfolio of Creative subsidiary

The settlement deal ends litigation by the Singapore company’s ZiiLabs unit against Nvidia, and will net shareholders around $17.5 million

11 February 2019

Apple’s courtroom strategy shows team monetising former portfolio of Blackberry patents faces biggest licensing challenge

The iPhone maker moves for declaratory judgment claiming non infringement of grants relating to charging technology

09 February 2019

The big life sciences patent developments in January

Record-breaking Celgene purchase, two decisions on the on-sale bar, Europe moves towards SPC manufacturing waiver, China proposes five-year patent term extension and much more

08 February 2019

The US’s first all biosimilar patent suit shows new pharma IP landscape is emerging

Coherus launched Delaware action against Amgen in what is likely to become an increasingly familiar life sciences litigation scenario.

08 February 2019

US patent system jumps to second in the world, though the biopharma sector may not agree

PTAB reforms help fuel a miraculous rise up the latest International IP Index, but a recent Federal Circuit decision on eligibility highlights the serious challenges that remain - especially for life sciences companies

07 February 2019

An entire “industry revolt” hinges on judge’s decision in FTC v Qualcomm

If the Commission and Apple are successful in rewriting the rules for chipmaker's licensing arm beware of unintended consequences that reduce choice and harm consumers, expert analyst states

07 February 2019

An insider look at the IP Asia Elite

The newest members of IAM's IP Asia Elite give us the inside scoop on what makes a great IP function tick  

05 February 2019

USPTO rules on patent term adjustment set to change following CAFC decision

The Federal Circuit’s precedential judgment in Supernus Pharmaceuticals v Iancu is good news for rights holders – especially those in life sciences